ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
177 hedge funds and large institutions have $375M invested in Antares Pharma, Inc. in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 57 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 162 → 177 (+15)
2% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 57
Holders
177
Holding in Top 10
4
Calls
$868K
Puts
$126K
Top Buyers
| 1 | +$7.8M | |
| 2 | +$5.52M | |
| 3 | +$3.85M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.41M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.22M |
Top Sellers
| 1 | -$5.66M | |
| 2 | -$2.24M | |
| 3 | -$857K | |
| 4 |
Barclays
London,
United Kingdom
|
-$760K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$687K |